XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -98.09%154M | -370.51%-587M | -195.79%-978M | -14.57%2.18B | -110.68%-456M | 28.62%8.05B | 113.77%217M | -69.36%1.02B | -24.09%2.55B | 270.89%4.27B |
Net income from continuing operations | 22.05%3.29B | 617.95%280M | 49.47%710M | 8.63%1.15B | 2.48%1.16B | 124.54%2.7B | 117.81%39M | -35.81%475M | 716.96%1.06B | 32.63%1.13B |
Operating gains losses | 21.05%-120M | -185.00%-17M | --0 | 94.62%-5M | -24.05%-98M | 73.61%-152M | 142.55%20M | --0 | -615.38%-93M | -2,533.33%-79M |
Depreciation and amortization | -4.02%1.24B | -0.32%314M | -4.57%313M | -5.85%306M | -5.23%308M | -9.58%1.29B | -10.26%315M | -9.14%328M | -0.91%325M | -16.67%325M |
Deferred tax | 116.67%13M | 98.91%-1M | -114.94%-26M | -6,300.00%-64M | 165.41%104M | 87.64%-78M | -280.39%-92M | 165.66%174M | 99.77%-1M | -1,425.00%-159M |
Other non cash items | -90.70%16M | 28.57%18M | -90.00%9M | -114.75%-9M | -128.57%-2M | 621.21%172M | 107.11%14M | 2,150.00%90M | -55.80%61M | -68.18%7M |
Change In working capital | -233.82%-4.52B | -577.09%-1.21B | -279.29%-2.03B | -34.31%739M | -167.78%-2.01B | 45.62%3.37B | 91.67%-179M | -120.11%-536M | -43.52%1.13B | 1,643.75%2.96B |
-Change in receivables | -82.06%-4.33B | -3,029.41%-1.6B | 16.52%-1.68B | -90.61%152M | 37.51%-1.21B | -46.28%-2.38B | 85.55%-51M | -14,457.14%-2.01B | -10.60%1.62B | 37.46%-1.94B |
-Change in payables and accrued expense | -115.54%-528M | -109.23%-25M | -52.13%1.2B | 68.49%-293M | -191.15%-1.41B | 707.13%3.4B | 202.26%271M | 288.99%2.51B | -1.53%-930M | 61.76%1.55B |
-Change in other current assets | 820.00%46M | -129.63%-32M | 117.12%482M | 800.00%70M | -50.48%-474M | -96.09%5M | 550.00%108M | -44.08%222M | -118.52%-10M | -5.35%-315M |
-Change in other current liabilities | -85.92%298M | -65.84%387M | -69.90%-2.1B | 81.26%890M | -35.16%1.12B | -34.64%2.12B | 183.25%1.13B | -301.30%-1.24B | -49.85%491M | -20.25%1.73B |
-Change in other working capital | -99.15%2M | 103.29%54M | 395.24%62M | -77.78%-80M | -101.75%-34M | 50.00%234M | 13.96%-1.64B | -101.10%-21M | -170.31%-45M | 2,295.06%1.94B |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -98.09%154M | -370.51%-587M | -195.79%-978M | -14.57%2.18B | -110.68%-456M | 28.62%8.05B | 113.77%217M | -69.36%1.02B | -24.09%2.55B | 270.89%4.27B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 11.67%-1.05B | 110.75%102M | -292.87%-839M | -175.24%-1.17B | 436.76%852M | 59.23%-1.19B | -529.41%-949M | 14,400.00%435M | 43.01%-424M | 89.46%-253M |
Capital expenditure reported | 19.40%-644M | 30.94%-154M | -12.50%-153M | 13.49%-186M | 32.89%-151M | 20.42%-799M | 4.29%-223M | 44.94%-136M | 23.76%-215M | 7.02%-225M |
Net business purchase and sale | 40.03%990M | 82.35%31M | --0 | -64.60%80M | 98.42%879M | -30.48%707M | -98.47%17M | -98.52%21M | 2,925.00%226M | 129.45%443M |
Net investment purchase and sale | -27.21%-1.4B | 130.28%225M | -224.73%-686M | -143.91%-1.06B | 126.33%124M | 62.54%-1.1B | -12.92%-743M | 147.13%550M | 4.61%-435M | 27.87%-471M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 11.67%-1.05B | 110.75%102M | -292.87%-839M | -175.24%-1.17B | 436.76%852M | 59.23%-1.19B | -529.41%-949M | 14,400.00%435M | 43.01%-424M | 89.46%-253M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -45.11%-2.41B | 93.53%-13M | -137.60%-1.25B | -56.13%-1.17B | 112.57%23M | 60.50%-1.66B | 88.39%-201M | 64.62%-524M | -54.32%-750M | 63.25%-183M |
Net issuance payments of debt | 3,468.42%678M | 609.39%922M | -112.03%-29M | -15.24%-378M | -43.21%163M | 101.68%19M | 33.21%-181M | 191.63%241M | -129.37%-328M | 163.36%287M |
Net common stock issuance | -93.71%-3.08B | -4,815.79%-934M | -59.24%-1.22B | -100.00%-792M | 66.67%-137M | 47.49%-1.59B | 98.67%-19M | 37.41%-763M | -17.16%-396M | -834.09%-411M |
Net other financing activities | 93.18%-6M | 0.00%-1M | 50.00%-1M | 96.15%-1M | 94.92%-3M | -114.63%-88M | 97.22%-1M | -300.00%-2M | -420.00%-26M | -5,800.00%-59M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -45.11%-2.41B | 93.53%-13M | -137.60%-1.25B | -56.13%-1.17B | 112.57%23M | 60.50%-1.66B | 88.39%-201M | 64.62%-524M | -54.32%-750M | 63.25%-183M |
Net cash flow | ||||||||||
Beginning cash position | 41.54%17.45B | -20.60%14.65B | 1.07%17.72B | 10.59%17.88B | 41.54%17.45B | -6.69%12.33B | 21.26%18.45B | 29.06%17.53B | 40.58%16.17B | -6.69%12.33B |
Current changes in cash | -163.49%-3.3B | 46.62%-498M | -428.54%-3.06B | -111.88%-163M | -89.07%419M | 707.23%5.2B | 69.78%-933M | -49.73%932M | -35.40%1.37B | 319.28%3.83B |
Effect of exchange rate changes | 125.00%8M | 101.96%1M | --0 | 111.11%1M | 200.00%6M | -190.91%-32M | -296.15%-51M | 192.86%26M | 78.57%-9M | -93.94%2M |
End cash Position | -18.89%14.16B | -18.89%14.16B | -20.60%14.65B | 1.07%17.72B | 10.59%17.88B | 41.54%17.45B | 41.54%17.45B | 21.26%18.45B | 29.06%17.53B | 40.58%16.17B |
Free cash flow | -106.75%-490M | -12,250.00%-741M | -227.80%-1.13B | -14.67%1.99B | -115.01%-607M | 37.99%7.25B | 99.67%-6M | -71.31%885M | -24.12%2.33B | 344.88%4.04B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |